Related Experiment Video
Updated: Aug 26, 2025

Spatiotemporal Subcellular Manipulation of the Microtubule Cytoskeleton in the Living Preimplantation Mouse Embryo using Photostatins
Published on: November 30, 2021
The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
1Team Cytoskeleton Dynamics and Nuclear Functions, Institute for Advanced Biosciences, Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Grenoble, France.
Abstract:
Compounds targeting microtubules are widely used in cancer therapy with a proven efficacy. However, because they also target non-cancerous cells, their administration leads to numerous adverse effects. With the advancement of knowledge on the structure of tubulin, the regulation of microtubule dynamics and their deregulation in pathological processes, new therapeutic strategies are emerging, both for the treatment of cancer and for other diseases, such as neuronal or even heart diseases and parasite infections. In addition, a better understanding of the mechanism of action of well-known drugs such as colchicine or certain kinase inhibitors contributes to the development of these new therapeutic approaches. Nowadays, chemists and biologists are working jointly to select drugs which target the microtubule cytoskeleton and have improved properties. On the basis of a few examples this review attempts to depict the panorama of these recent advances.
Insights
Compounds targeting microtubules are crucial for cancer therapy but cause side effects. New research focuses on improved microtubule-targeting drugs for cancer and other diseases like neuronal disorders and infections.
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology
- Cell Biology
Background:
- Microtubule-targeting compounds are established cancer therapeutics.
- Current therapies exhibit significant adverse effects due to targeting non-cancerous cells.
- Advancements in understanding tubulin structure and microtubule dynamics are key.
Purpose of the Study:
- To review recent advances in microtubule-targeting drugs.
- To explore emerging therapeutic strategies beyond cancer treatment.
- To highlight the collaborative efforts of chemists and biologists in drug development.
Main Methods:
- Review of current literature on microtubule-targeting agents.
- Analysis of drug mechanisms of action, including established drugs like colchicine.
- Examination of new therapeutic approaches for various diseases.
Main Results:
- Emerging therapeutic strategies target microtubule dynamics for improved efficacy and reduced toxicity.
- New drug candidates show potential for treating cancer, neuronal diseases, heart conditions, and parasitic infections.
- Understanding drug mechanisms, such as colchicine and kinase inhibitors, aids in developing novel agents.
Conclusions:
- Targeting the microtubule cytoskeleton offers promising therapeutic avenues for diverse diseases.
- Interdisciplinary collaboration is accelerating the development of safer and more effective microtubule-targeting drugs.
- Future research will likely yield improved treatments by refining our knowledge of microtubule regulation.
More Related Videos
07:21Quantitative Microtubule Fractionation Technique to Separate Stable Microtubules, Labile Microtubules, and Free Tubulin in Mouse Tissues
Published on: November 17, 2023
06:02Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microtubule Associated Proteins (MAPs)